Palmitoyl Tripeptide-38

Mechanism

The most comprehensive matrix-rebuilding cosmetic peptide available. Instead of stimulating just one or two skin components, it triggers production of 6 major structural components: collagen I, III, and IV, fibronectin, hyaluronic acid, and laminin-5. Think of it as a "full renovation" peptide for the skin's structural framework.

Effects

## Integumentary System — Comprehensive ECM Stimulation [Tier 2 — Moderate Human Data] Palmitoyl-Tripeptide-38 (Pal-VGVAPG, trade name Matrixyl Synthe'6) is a lipopeptide that mimics the biological activity of Thrombospondin-1 (TSP-1), a matricellular protein involved in wound healing and tissue remodeling. It uniquely stimulates synthesis of all 6 major structural components of the dermal-epidermal junction and dermis simultaneously: 1. **Collagen I** — primary structural protein (dermis) — increased 100-200% 2. **Collagen III** — "young collagen," predominant in fetal skin and early wound healing — increased significantly 3. **Collagen IV** — basement membrane component (dermal-epidermal junction integrity) — increased 200-300% 4. **Fibronectin** — cell adhesion and migration scaffold — increased 100-150% 5. **Hyaluronic acid** — via HAS upregulation — increased 150-200% 6. **Laminin 5 (Laminin-332)** — critical basement membrane adhesion molecule — increased 100-150% This "6-in-1" stimulation is the key differentiator from other cosmetic peptides, which typically stimulate only 1-2 ECM components. The effect is attributed to activation of latent TGF-beta through TSP-1-mimetic signaling.

Practitioner Guide

## Practical Formulation Guide ### Why Matrixyl Synthe'6 May Be the Best Single Peptide Choice If a formulator could choose only ONE anti-aging peptide, Matrixyl Synthe'6 has a strong argument: it addresses all 6 major ECM components simultaneously. Most other peptides address collagen alone. The addition of collagen IV, laminin 5 (basement membrane integrity), and hyaluronic acid provides a comprehensive structural support that no other single peptide matches. ### Effective Concentrations - **Manufacturer-recommended:** 2-4% of commercial Matrixyl Synthe'6 solution. - **Active peptide in finished product:** 50-200 ppm. ### Formulation Considerations - **pH:** Stable at pH 5.0-7.0. - **Compatibility:** Compatible with all major cosmetic peptides. Can be combined with Argireline, other Matrixyl variants, Syn-Ake, Pal-Tripeptide-5, etc. - **Vehicle:** Amphiphilic — works in aqueous serums and emulsions. - **Heat stability:** Moderate. Add below 40°C for best results. ### How It Differs From Other Matrixyl Variants - **Original Matrixyl (Pal-KTTKS):** Stimulates collagen I, III primarily. Good workhorse peptide. - **Matrixyl 3000 (Pal-GHK + Pal-GQPR):** Collagen I stimulation + anti-inflammatory. Best for photo-damaged/inflamed skin. - **Matrixyl Synthe'6 (Pal-Tripeptide-38):** 6-component ECM stimulation. The most comprehensive single peptide for structural anti-aging. ### Application in Multi-Peptide Formulations **Premium anti-aging serum formula approach:** - Matrixyl Synthe'6 (4%) — comprehensive ECM - Argireline (10%) — expression lines - Syn-Ake (3%) — deeper expression line relaxation - Pal-Tripeptide-5 (2%) — TGF-beta pathway collagen Total: 4 peptides addressing different aging mechanisms — all compatible in one aqueous serum at pH 5.5-6.0. ### Realistic Expectations - **2 weeks:** Improved hydration (HA synthesis begins rapidly). Skin texture feels smoother. - **4 weeks:** Early firmness improvement. Hydration effect well-established. - **8 weeks:** 20-30% wrinkle depth reduction in clinical measurements. Skin appears plumper and more resilient. - **12-24 weeks:** Maximum benefit. Combined collagen and HA increase creates visible skin thickening and "bounce." Basement membrane strengthening (collagen IV, laminin 5) improves dermal-epidermal adhesion — skin is more resilient to mechanical stress.

Evidence

• A serum containing vitamins C & E and a matrix-repair tripeptide reduces facial signs of aging as evidenced by Primos® analysis and frequently repeated auto-perception.

  Lintner et al. (2020) — Journal of Cosmetic Dermatology — PMID: 33103342

  Open-label 56-day facial-aging study reported statistically significant improvements in skin roughness, isotropy, redness, and perceived wrinkles with a multi-ingredient serum containing palmitoyl tripeptide-38; signal is supportive but limited by open-label design and combination formulation.

  emerging

Research Summary

## Tier 1 — Strong Clinical Evidence - Well-characterized mechanism (TSP-1 mimetic activating latent TGF-beta for coordinated ECM synthesis) - Widely used commercial ingredient with extensive manufacturer clinical data ## Tier 2 — Moderate Evidence - Clinical studies (Sederma) showing 20-30% wrinkle depth reduction after 8-12 weeks of twice-daily application - In vitro data confirming simultaneous upregulation of 6 ECM components (collagen I, III, IV, fibronectin, HA, laminin 5) - Comparison studies suggesting superior efficacy to original Matrixyl for overall skin structural improvement (attributed to multi-component stimulation) ## Tier 3 — Preclinical/Theoretical - Potential application in wound healing (broad ECM stimulation could accelerate tissue repair) - Basement membrane strengthening (collagen IV, laminin 5) may have implications for preventing age-related skin fragility - Independent academic validation limited — most data from ingredient manufacturer